Henri Beaufour

Henri Beaufour (born January 1965) is a French businessman and billionaire. He is a descendant of Henri Beaufour, founder of the Beaufour laboratories, forerunner of the French biopharmaceutical company Ipsen.[1]  

Henri Beaufour
Born
Henri Pierre Albert Marie Beaufour

January 1965 (age 58)
NationalityFrench
Alma materGeorgetown University
Board member ofIpsen
ParentAlbert Beaufour
RelativesAnne Beaufour (sister)

Biography

Born in January 1965, in Neuilly-sur-Seine, Henri Beaufour is the son of Albert Beaufour, who died in 2000, and the grandson of Dr. Henri Beaufour, founder of the Ipsen group.[1]

He holds a bachelor's of arts from Georgetown University (Washington, D.C.).

When Albert Beaufour died in 2000, the 76% of the capital held by the family was divided between the three brothers and sisters. One of the daughters, Véronique Beaufour, sold her share, representing 6% of the capital. Anne and her brother Henri Beaufour thus control 57% of the Ipsen group, and both sit on the Board of Directors of Ipsen and Mayroy, the Ipsen controlling holding company. Their share in Ipsen is still 52% in 2020.[2]  

In 2018, his fortune is estimated at Euro 3 billion.[3][4]

References
  1. Mariette Finet & Elisabeth Hennebert (2012). From Beaufour to Ipsen. Qualibris edition.
  2. "Un nouveau président pour Beaufour-Ipsen". Les Echos (in French). 2001-12-05. Retrieved 2022-12-13.
  3. "Henri Beaufour". Forbes. Retrieved 2022-12-13.
  4. Challenges (2022-06-06). "Anne Beaufour et Henri Beaufour ainsi que leur famille - Les 500 plus grandes fortunes de France". Challenges (in French). Retrieved 2022-12-13.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.